Classification of test agent-specific effects in the Syrian hamster embryo assay (pH 6.7) using infrared spectroscopy with computational analysis

Mutagenesis

Volumn 27, Issue 3, 2012, Pages 375-382

  Ahmadzai, Abdullah A ^a   Trevisan, Júlio ^a   Pang, Weiyi ^a   Patel, Imran I ^a   Fullwood, Nigel J ^b   Bruce, Shannon W ^c   Pant, Kamala ^c   Carmichael, Paul L ^d   Scott, Andrew D ^d   Martin, Francis L ^a  

^a LANCASTER UNIVERSITY   (United Kingdom)

^b LANCASTER UNIVERSITY   (United Kingdom)

^c BioReliance Corporation   (United States)

^d UNILEVER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DIAMINOTOLUENE; 3 METHYLCHOLANTHRENE; AMIDE; ANTHRACENE; BENZO[A]PYRENE; MANNITOL; METHYLNITRONITROSOGUANIDINE; TOLUIDINE DERIVATIVE;

ALGORITHM; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOASSAY; CELL ASSAY; CELL CULTURE; CELL TRANSFORMATION; CONTROLLED STUDY; EMBRYO CELL; FIXATION DEVICE; GENOTOXICITY; HISTOGRAM; IN VIVO STUDY; INFRARED SPECTROSCOPY; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; SCREENING; SENSITIVITY AND SPECIFICITY; SYRIAN HAMSTER; SYRIAN HAMSTER EMBRYO ASSAY;

ANIMALS; BIOLOGICAL MARKERS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CRICETINAE; DATA INTERPRETATION, STATISTICAL; EMBRYO, MAMMALIAN; HYDROGEN-ION CONCENTRATION; LINEAR MODELS; MESOCRICETUS; MUTAGENICITY TESTS; MUTAGENS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84860194781     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ges003     Document Type: Article

References (51)

1. Kirkland, D., Aardema, M., Henderson, L. and Müller, L. (2005) Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Mutat. Res., 584, 1-256.
2. LeBoeuf, R. A., Kerckaert, G. A., Aardema, M. J., Gibson, D. P., Brauninger, R. and Isfort, R. J. (1996) The pH 6.7 Syrian hamster embryo cell transformation assay for assessing the carcinogenic potential of chemicals. Mutat. Res., 356, 85-127.
3. Kerckaert, G. A., Brauninger, R., LeBoeuf, R. A. and Isfort, R. J. (1996) Use of the Syrian hamster embryo cell transformation assay for carcinogenicity prediction of chemicals currently being tested by the National Toxicology Program in rodent bioassays. Environ. Health Perspect., 104, 1075-1084.
4. Isfort, R. J., Kerckaert, G. A. and LeBoeuf, R. A. (1996) Comparison of the standard and reduced pH Syrian hamster embryo (SHE) cell in vitro transformation assays in predicting the carcinogenic potential of chemicals. Mutat. Res., 356, 11-63.
5. Berwalds, Y. and Sachs, L. (1963) In vitro cell transformation with chemical carcinogens. Nature, 200, 1182-1184.
6. LeBoeuf, R. A. and Kerchaert, G. A. (1987) Enhanced morphological transformation of early passage Syrian hamster embryo cells cultured in medium with a reduced bicarbonate concentration and pH. Carcinogenesis, 8, 689-697.
7. Isfort, R. J., Cody, D. B., Kerckaert, G. A., Tycko, B. and LeBoeuf, R. A. (1997) Role of the H19 gene in Syrian hamster embryo cell tumorigenicity. Mol. Carcinog., 20, 189-193.
8. Matouk, I. J., Mezan, S., Mizrahi, A., Ohana, P., Abu-Lail, R., Fellig, Y., deGroot, N., Galun, E. and Hochberg, A. (2010) The oncofetal H19 RNA connection: hypoxia, p53 and cancer. Biochim. Biophys. Acta., 1803, 443-451.
9. Brannan, C. I., Dees, E. C., Ingram, R. S. and Tilghman, S. M. (1990) The product of the H19 gene may function as an RNA. Mol. Cell. Biol., 10, 28-36.
10. Bartolomei, M. S., Zemel, S. and Tilghman, S. M. (1991) Parental imprinting of the mouse H19 gene. Nature, 351, 153-155.
11. Gabory, A., Jammes, H. and Dandolo, L. (2010) The H19 locus: role of an imprinted non-coding RNA in growth and development. Bioessays, 32, 473-480.
12. Poirier, F., Chan, C. T., Timmons, P. M., Robertson, E. J., Evans, M. J. and Rigby, P. W. (1991) The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. Development, 113, 1105-1114.
13. Maire, M. A., Rast, C., Pagnout, C. and Vasseur, P. (2005) Changes in expression of bcl-2 and bax in Syrian hamster embryo (SHE) cells exposed to ZnCl2. Arch. Toxicol., 79, 90-101.
14. Maire, M. A., Rast, C., Landkocz, Y. and Vasseur, P. (2007) 2,4- Dichlorophenoxyacetic acid: effects on Syrian hamster embryo (SHE) cell transformation, c-Myc expression, DNA damage and apoptosis. Mutat. Res., 631, 124-136.
15. Isfort, R. J. and LeBoeuf, R. A. (1995) The Syrian hamster embryo (SHE) cell transformation system: a biologically relevant in vitro model-with carcinogen predicting capabilities-of in vivo multistage neoplastic transformation. Crit. Rev. Oncog., 6, 251-260.
16. Custer, L., Gibson, D. P., Aardema, M. J. and LeBoeuf, R. A. (2000) A refined protocol for conducting the low pH 6.7 Syrian hamster embryo (SHE) cell transformation assay. Mutat. Res., 455, 129-139.
17. Ridder, G. M., Stuard, S. B., Kerckaert, G. A., Cody, D. B., LeBoeuf, R. A. and Isfort, R. J. (1997) Computerized image analysis of morphologically transformed and nontransformed Syrian hamster embryo (SHE) cell colonies: application to objective SHE cell transformation assay scoring. Carcinogenesis, 18, 1965-1972.
18. LeBoeuf, R. A., Kerckaert, G. A., Aardema, M. J. and Gibson, D. P. (1990) Multistage neoplastic transformation of Syrian hamster embryo cells cultured at pH 6.70. Cancer Res., 50, 3722-3729.
19. Walsh, M. J., Bruce, S. W., Pant, K., Carmichael, P. L., Scott, A. D. and Martin, F. L. (2009) Discrimination of a transformation phenotype in Syrian golden hamster embryo (SHE) cells using ATR-FTIR spectroscopy. Toxicology, 258, 33-38.
20. Trevisan, J., Angelov, P. P., Patel, I. I. et al. (2010) Syrian hamster embryo (SHE) assay (pH 6.7) coupled with infrared spectroscopy and chemometrics towards toxicological assessment. Analyst, 135, 3266-3272.
21. Pant, K., Sly, J. E., Bruce, S. W., Scott, A. D., Carmichael, P. L. and San, R. H. (2010) Syrian Hamster Embryo (SHE) cell transformation assay with and without X-ray irradiation of feeder cells using Di(2-ethylhexyl) phthalate (DEHP) and N-nitroso-N-methylnitroguanidine (MNNG). Mutat. Res., 698, 6-10.
22. Fearn, T. (2002) Discriminant analysis. In Chalmers, J. and Griffiths, P. R. (eds.) Handbook of Vibrational Spectroscopy. 3, John Wily and Sons, New York, pp. 2086-2093.
23. Guyon, I. and Elisseeff, A. (2003) An introduction to variable and feature selection. J. Mach. Learn. Res., 3, 1157-1182.
24. Hammiche, A., German, M. J., Hewitt, R., Pollock, H. M. and Martin, F. L. (2005) Monitoring cell cycle distributions in MCF-7 cells using near-field photothermal microspectroscopy. Biophys. J., 88, 3699-3706.
25. Martin, F. L., German, M. J., Wit, E., Fearn, T., Ragavan, N. and Pollock, H. M. (2007) Identifying variables responsible for clustering in discriminant analysis of data from infrared microspectroscopy of a biological sample. J. Comput. Biol., 14, 1176-1184.
26. Hastie, T., Tibshirani, R. and Friedman, J. (2001) The Elements of Statistical Learning. Springer Series in Statistics. Springer, New York.
27. Sun, G., Jin, S. and Baskaran, R. (2009) MMR/c-Abl-dependent activation of ING2/p73α signaling regulates the cell death response to N-methyl-N'- nitro-N-nitrosoguanidine. Exp. Cell Res., 315, 3163-3175.
28. Loveless, A. (1969) Possible relevance of O-6 alkylation of deoxyguanosine to the mutagenicity and carcinogenicity of nitrosamines and nitrosamides. Nature, 223, 206-207.
29. Xie, Y., Abdallah, M. E., Awonuga, A. O., Slater, J. A., Puscheck, E. E. and Rappolee, D. A. (2010) Benzo(a)pyrene causes PRKAA1/2-dependent ID2 loss in trophoblast stem cells. Mol. Reprod. Dev., 77, 533-539.
30. Drukteinis, J. S., Medrano, T., Ablordeppey, E. A., Kitzman, J. M. and Shiverick, K. T. (2005) Benzo[a]pyrene, but not 2,3,7,8-TCDD, induces G2/ M cell cycle arrest, p21CIP1 and p53 phosphorylation in human choriocarcinoma JEG-3 cells: a distinct signaling pathway. Placenta, 26, 87-95.
31. Rappolee, D., Awonuga, A., Puscheck, E., Chow, S. and Xie, X. (2010) Benzopyrene and experimental stressors cause differentiation in placental trophoblast stem cells. Syst. Biol. Reprod. Med, 56, 168-183.
32. Zhang, L. and Shiverick, K. T. (1997) Benzo(a)pyrene, but not 2,3,7,8- tetrachlorodibenzo-p-dioxin, alters cell proliferation and c-myc and growth factor expression in human placental choriocarcinoma JEG-3 cells. Biochem. Biophys. Res. Commun, 231, 117-120.
33. Zhang, L., Connor, E. E., Chegini, N. and Shiverick, K. T. (1995) Modulation by benzo[a]pyrene of epidermal growth factor receptors, cell proliferation, and secretion of human chorionic gonadotropin in human placental cell lines. Biochem. Pharmacol., 50, 1171-1180.
34. Malins, D. C., Anderson, K. M., Gilman, N. K., Green, V. M., Barker, E. A. and Hellström, K. E. (2004) Development of a cancer DNA phenotype prior to tumor formation. Proc. Natl Acad. Sci. USA, 101, 10721-10725.
35. Quattrochi, L. C., Vu, T. and Tukey, R. H. (1994) The human CYP1A2 gene and induction by 3-methylcholanthrene. A region of DNA that supports AH-receptor binding and promoter-specific induction. J. Biol. Chem., 269, 6949-6954.
36. Atlas, S. A., Taylor, B. A., Diwan, B. A. and Nebert, D. W. (1976) Genetic aspects of toxicity during development. Genetics, 83, 537-550.
37. Shimokado, K., Watanabe, H., Sumii, M., Miyagawa, K., Kamiya, K., Dohi, K. and Niwa, O. (1998) p53 gene mutation and loss of heterozygosity of chromosome 11 in methylcholanthrene-induced mouse sarcomas. Jpn. J. Cancer Res., 89, 269-277.
38. Takemura, H., Nagayoshi, H., Matsuda, T., Sakakibara, H., Morita, M., Matsui, A., Ohura, T. and Shimoi, K. (2010) Inhibitory effects of chrysoeriol on DNA adduct formation with benzo[a]pyrene in MCF-7 breast cancer cells. Toxicology, 274, 42-48.
39. Gaber, K., Harréus, U. A., Matthias, C., Kleinsasser, N. H. and Richter, E. (2007) Hemoglobin adducts of the human bladder carcinogen o-toluidine after treatment with the local anesthetic prilocaine. Toxicology, 229, 157-164.
40. Rubino, G. F., Scansetti, G., Piolatto, G. and Pira, E. (1982) The carcinogenic effect of aromatic amines: an epidemiological study on the role of o-toluidine and 4,4-methylene bis(2-methylaniline) in inducing bladder cancer in man. Environ. Res., 27, 241-254.
41. Ward, E., Carpenter, A., Markowitz, S., Roberts, D. and Halperins, W. (1991) Excess numbers of bladder cancers in workers exposed to orthotoluidine and aniline. J. Natl Cancer Inst., 83, 501-506.
42. Séverin, I., Jondeau, A., Dahbi, L. and Chagnon, M. C. (2005) 2,4- Diaminotoluene (2,4-DAT)-induced DNA damage, DNA repair and micronucleus formation in the human hepatoma cell line HepG2. Toxicology, 213, 138-146.
43. Ames, B. N., Kammen, H. O. and Yamasaki, E. (1975) Hair dyes are mutagenic: identification of a variety of mutagenic ingredients. Proc. Natl Acad. Sci. USA, 72, 2423-2427.
44. Ito, N., Hiasa, Y., Konishi, Y. and Marugami, M. (1969) The development of carcinoma in liver of rats treated with m-toluylenediamine and the synergistic and antagonistic effects with other chemicals. Cancer Res., 29, 1137-1142.
45. Cheung, Y. L., Snelling, J., Mohammed, N. N. D., Gray, T. J. B. and Ioannides, C. (1996) Interaction with the aromatic hydrocarbon receptor, CYP1A induction, and mutagenicity of a series of diaminotoluenes: implications for their carcinogenicity. Toxicol. Appl. Pharmacol., 139, 203-211.
46. Creton, S., Aardema, M. J., Carmichael, P. L. et al. (2012) Cell transformation assays for prediction of carcinogenic potential: state of the science and future research needs. Mutagenesis, 27, 93-101.
47. Martin, F. L., Kelly, J. G., Llabjani, V., Martin-Hirsch, P. L., Patel, I. I., Trevisan, J., Fullwood, N. J. and Walsh, M. J. (2010) Distinguishing cell types or populations based on the computational analysis of their infrared spectra. Nat. Protoc., 5, 1748-1760.
48. Kelly, J. G., Trevisan, J., Scott, A. D., Carmichael, P. L., Pollock, H. M., Martin-Hirsch, P. L. and Martin, F. L. (2011) Biospectroscopy to metabolically profile biomolecular structure: a multistage approach linking computational analysis with biomarkers. J. Proteome Res., 10, 1437-1448.
49. - modifications as a marker of the putative stem cell region of human intestinal crypts. Stem Cells, 26, 108-118.
50. Hodges, M. D., Kelly, J. G., Bentley, A. J., Fogarty, S., Patel, I. I., Martin, F. L. and Fullwood, N. J. (2011) Combining immunolabeling and surface-enhanced Raman spectroscopy on cell membranes. ACS Nano, 5, 9535-9541.
51. Benigni, R. and Bossa, C. (2011) Alternative strategies for carcinogenicity assessment: an efficient and simplified approach based on in vitro mutagenicity and cell transformation assays. Mutagenesis, 26, 455-460.